{"brief_title": "Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women", "brief_summary": "The purpose of this study is to test the safety and effectiveness of two different formulations of an HIV vaccine in infants born to HIV-infected women.", "condition": ["HIV Infections", "HIV Seronegativity"], "intervention_type": ["Biological", "Biological", "Biological"], "intervention_name": ["Aluminum hydroxide", "QS-21", "MN rsgp120/HIV-1"], "criteria": "Inclusion Criteria Infants may be eligible for this study if they: - Are 1 to 3 days old.", "gender": "All", "minimum_age": "N/A", "maximum_age": "3 Days", "healthy_volunteers": "Accepts Healthy Volunteers", "keyword": "HIV Therapeutic Vaccine", "mesh_term": ["HIV Infections", "Vaccines", "Aluminum Hydroxide", "QS 21"], "id": "NCT00000809"}